News

Jeantet assisted the Guyot Group in connection with Epopée Gestion’s investment

Paris, 12 December 2025 – Jeantet advised Guyot Energies (a subsidiary of the Guyot group) in connection with the investment of Epopée Gestion funds to accelerate the development of local low carbon energy sources. Guyot Energies, a subsidiary of the Guyot group dedicated to energy transition, and Epopée Gestion, a regional investment fund, have decided […]

Paris | LISTED COMPANIES AND CAPITAL MARKETS LAW

+

| CORPORATE – M&A – PRIVATE EQUITY

+

Les défaillances en France font une pause en trompe-l’oeil – L’Agefi 04/04/2025

Plus de 66.000 procédures encore ont été ouvertes sur douze mois à fin février, selon la Banque de France. Read the article: here

| RESTRUCTURING – LAW OF COMPANIES IN DIFFICULTY

+

A closer look at the Euro PP, USPP and schulschein standard, based on their standad documentation, IGTA Winter Journal 2024/2025

A closer look at the Euro PP, USPP and schulschein standard, based on their standad documentation, IGTA Winter Journal 2024/2025

+

Jeantet advised Cusp Capital Partners, lead investor in the EUR 8 million Seed financing of 2501.ai

Paris, 5 December 2025 – Jeantet advised Cusp Capital Partners in connection with the EUR 8 million Seed financing of 2501.ai, a French company developing autonomous AI agents designed to automate the management of IT and cloud infrastructures. 2501.ai is building a next-generation platform of autonomous AI agents capable of detecting and automatically resolving incidents […]

| CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises Iris Ventures, lead investor in the usd 15 million Series B of Innerskin

Paris, 4 December 2025 – Jeantet advised Iris Ventures on the USD 15 million Series B of Innerskin, active in the modern aesthetic medicine sector. Through its 19 centers in France, Innerskin offers a distinctive approach focused on preventative facial and body care, combining high-performance technologies, holistic expertise and premium client experience, by pairing in-clinic […]

| CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises the Hyg’up Group on the sale of Amplitude Services to Laboratoires Ceetal

Paris, November 27, 2025 – Jeantet advised the Hyg’Up group on a strategic carve-out of Amplitude Services’ activities. This transaction is a decisive step in the Hyg’Up group’s strategy of refocusing on its core business activities, enabling it to concentrate its resources and expertise on priority strategic business segments while optimizing the group’s operational performance. […]

| CORPORATE – M&A – PRIVATE EQUITY

+

Paris, June 25, 2025 – Jeantet advised LBO France and Andera Acto on the sale of Prenax, a specialist in outsourced subscription and non-strategic purchasing management, to the pan-European fund Triton Partners. The Jeantet team drew on its multidisciplinary expertise, with Pascal Georges (Partner), David Hallel and Nicolas Méheust (Associates) handling corporate matters, Gabriel Di […]

| CORPORATE – M&A – PRIVATE EQUITY | TAX | EMPLOYMENT

+

Jeantet advises Entreprise Redonnaise d’Électricité on the acquisition of the Ardelec Énergie Group

Paris, November 17, 2025 – Jeantet advised Entreprise Redonnaise d’Électricité (ERE) on the acquisition of Ardelec Energie, an external growth transaction carried out less than a year after LBO France Gestion acquired a majority stake in ERE. Based in Redon, Bretagne, ERE designs and manufactures prefabricated concrete transformer stations, mainly for industrial customers. Ardelec Energie, […]

| CORPORATE – M&A – PRIVATE EQUITY | EMPLOYMENT | TAX LAW | FINANCING

+

French Competition Authority sanctions a predatory acquisition for the first time on the basis of abuse of a dominant position

French Competition Authority (Autorité de la concurrence) has taken a new step in applying the Towercast case law (CJEU, 16 March 2023) by sanctioning for the first time a merger transaction on the basis of abuse of a dominant position. In this article, Renaud Christol and Paul Vialard analyze the key lessons from this decision […]

| COMPETITION AND ECONOMIC LAW

+

+

In a ruling handed down on October 18, 2025, the CJEU ruled in Case C-2/24 P, Teva v. Cephalon v. European Commission, clarifying the conditions under which an amicable settlement agreement between patent holders and generic manufacturers can be classified as an anti-competitive agreement. In this article, Renaud Christol and Paul Vialard review the implications […]

| COMPETITION AND ECONOMIC LAW

+

Passionate visionaries, focused on your success